Francisco A. Bonilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Francisco A. Bonilla has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Avni Joshi
Division of Allergy/Immunology, Mayo Clinic Children's Center, Rochester, Minn
1 shared publication- Brian D. Stadinski
Department of Pathology, University of Massachusetts Chan Medical School, Worcester, USA
1 shared publication - Christina Yee
Division of Immunology, Boston Children's Hospital, Boston, MA
1 shared publication - Claudia Wehr
Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
1 shared publication Eric S. Huseby
Department of Pathology, University of Massachusetts Medical School, Worcester, MA
1 shared publicationHans D. Ochs
University of Washington and Seattle Children's Hospital, Seattle, Wash
1 shared publication
Latest Publications
- 24 May 2018
- Published by American Society of Hematology in Blood
- Vol. 131 (21) , 2335-2344
Patients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function
Integrity of the T-cell receptor/CD3 complex is crucial for positive and negative selection of T cells in the thymus and for effector and regulatory functions of peripheral T lymphocytes. In humans, CD3D, CD3E, and CD3Z gene defects are a cause of severe immune deficiency and present early in life with increased susceptibility to infections. By contrast, CD3G mutations lead to milder phenotypes, mainly characterized by autoimmunity. However, the role of CD3γ in establishing and maintaining immune tolerance has not been elucidated. In this manuscript, we aimed to investigate abnormalities of T-cell repertoire and function in patients with genetic defects in CD3G associated with autoimmunity. High throughput sequencing was used to study composition and diversity of the T-cell receptor β (TRB) repertoire in regulatory T cells (Tregs), conventional CD4+ (Tconv), and CD8+ T cells from 6 patients with CD3G mutations and healthy controls. Treg function was assessed by studying its ability to suppress proliferation of Tconv cells. Treg cells of patients with CD3G defects had reduced diversity, increased clonality, and reduced suppressive function. The TRB repertoire of Tconv cells from patients with CD3G deficiency was enriched for hydrophobic amino acids at positions 6 and 7 of the CDR3, a biomarker of self-reactivity. These data demonstrate that the T-cell repertoire of patients with CD3G mutations is characterized by a molecular signature that may contribute to the increased rate of autoimmunity associated with this condition. Key Points CD3γ-deficient patients manifest T-cell phenotypic and functional defects that are especially prominent in Treg cells. The peripheral T-cell repertoire of CD3γ-deficient patients is restricted, with molecular signatures of self-reactivity. Visual Abstract
- 24 May 2018
- Published by American Society of Hematology in Blood
- Vol. 131 (21) , 2335-2344
Patients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function
Integrity of the T-cell receptor/CD3 complex is crucial for positive and negative selection of T cells in the thymus and for effector and regulatory functions of peripheral T lymphocytes. In humans, CD3D, CD3E, and CD3Z gene defects are a cause of severe immune deficiency and present early in life with increased susceptibility to infections. By contrast, CD3G mutations lead to milder phenotypes, mainly characterized by autoimmunity. However, the role of CD3γ in establishing and maintaining immune tolerance has not been elucidated. In this manuscript, we aimed to investigate abnormalities of T-cell repertoire and function in patients with genetic defects in CD3G associated with autoimmunity. High throughput sequencing was used to study composition and diversity of the T-cell receptor β (TRB) repertoire in regulatory T cells (Tregs), conventional CD4+ (Tconv), and CD8+ T cells from 6 patients with CD3G mutations and healthy controls. Treg function was assessed by studying its ability to suppress proliferation of Tconv cells. Treg cells of patients with CD3G defects had reduced diversity, increased clonality, and reduced suppressive function. The TRB repertoire of Tconv cells from patients with CD3G deficiency was enriched for hydrophobic amino acids at positions 6 and 7 of the CDR3, a biomarker of self-reactivity. These data demonstrate that the T-cell repertoire of patients with CD3G mutations is characterized by a molecular signature that may contribute to the increased rate of autoimmunity associated with this condition. Key Points CD3γ-deficient patients manifest T-cell phenotypic and functional defects that are especially prominent in Treg cells. The peripheral T-cell repertoire of CD3γ-deficient patients is restricted, with molecular signatures of self-reactivity. Visual Abstract
- 1 November 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (5) , 1436-1439.e11
Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies
- 1 November 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (5) , 1436-1439.e11
Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies
- 1 November 2013
- Published by Oxford University Press (OUP)
- p. 780-806
Assessment of the Immune System
Primary immunodeficiency diseases are inherited disorders that affect human adaptive and innate immunity. In most cases, affected individuals experience recurrent infections, but they may also suffer from autoimmune diseases and malignancies. This chapter focuses on the assessment of the Immune System, including the historic and scientific background, clinical presentations, immunologic characteristics, and the molecular/genetic underpinnings. Where appropriate, diagnostic tools and therapeutic options are outlined -- from prophylactic anti-infective measures to hematopoietic stem cell transplantation and gene therapy.
- 1 November 2013
- Published by Oxford University Press (OUP)
- p. 780-806
Assessment of the Immune System
Primary immunodeficiency diseases are inherited disorders that affect human adaptive and innate immunity. In most cases, affected individuals experience recurrent infections, but they may also suffer from autoimmune diseases and malignancies. This chapter focuses on the assessment of the Immune System, including the historic and scientific background, clinical presentations, immunologic characteristics, and the molecular/genetic underpinnings. Where appropriate, diagnostic tools and therapeutic options are outlined -- from prophylactic anti-infective measures to hematopoietic stem cell transplantation and gene therapy.